Arch Pharmalabs IPO – Review, Bid, Size, Allotment, Subscription, GMP & DRHP
Last Updated Date: Nov 16, 2022Let’s have a detailed review of the company and analytics of the Arch Pharmalabs IPO release date, IPO offer price, subscription, Arch Pharmalabs Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.
Face Value | Rs 10 |
Price Band | Rs [●] |
Listing At | BSE, NSE |
Min. Order Quantity | NA |
Listing Date | NA |
Offer for Sale | Rs Million |
Fresh Issue | Rs Million |
IPO Size | Rs Million |
Tick Size | 1 |
Arch Pharmalabs IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.
Arch Pharmalabs Share Price – Live Performance |
Arch Pharmalabs IPO – Summary
Arch Pharmalabs belongs to the arena of Pharmaceutical Company. Its line of business is into both products and services from the said domain. Speaking of the products they are into, they manufacture and sell APIs and intermediates to innovator generic pharmaceutical players.
They have expanded and sell their products in the local as well as international market. There is also an inclusion of Regulated markets. The company uses a lot of combinations to manufacture the products.
The Promoter of this company is Mr. Manish Kumar Dabkara. The lead manager to the issue is HEM SECURITIES LIMITED, and the Registrar to this issue is BIG SHARE SERVICES PRIVATE LIMITED.
Arch Pharmalabs IPO Date
The opening and the closing date of the IPO of Arch Pharmalabs Limited are not available yet.
Arch Pharmalabs IPO Subscription
Day / Date | QIB | NII | RII | Total Subscription |
1st Day – | ||||
2nd Day – | ||||
3rd Day – | ||||
Shares Offered or Net Issue |
The shares subscribed by the public will be updated here.
Check Arch Pharmalabs IPO LIVE Subscription
- Arch Pharmalabs IPO LIVE Bid details on BSE
- Arch Pharmalabs IPO LIVE Bid details on NSE
For the Latest Bid details click on the above links.
Arch Pharmalabs IPO Allotment Status
Here, you can find the Allotment Status of this IPO.
Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.
Arch Pharmalabs Limited IPO Listing Date
Find the dates below on basis of allotment, refund, listing, and more:
Basis of Allotment Finalization | – |
Refunds Initiation | – |
Credit of Shares to Demat Account | – |
Share Listing Date | – |
Arch Pharmalabs IPO Price Band / Cash Price
The face value of each share is Rs.10, but the price band of the IPO is Rs.[●]
Arch Pharmalabs IPO Equity Size
This Initial Public Issue of 18,24,000 Equity Shares of Rs.10 each for cash at a price of Rs.[●] per equity share aggregating to Rs.[●] Million.
Arch Pharmalabs IPO Share Offering
Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of [●] equity Shares of Rs.10/ each.
Issue Size: X Equity Shares of Rs.10 each, aggregating to Rs.[●] Million
Open Free Demat Account Now!
Arch Pharmalabs IPO – Live Performance
The listing date of this IPO is [●]. You can check the live performance of the IPO here, only after it is listed on exchanges.
Live IPO Performance – Arch Pharmalabs Share Price |
Arch Pharmalabs IPO Grey Market Premium
The Arch Pharmalabs Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is X.
Arch Pharmalabs IPO – Company Overview
Involved in production and sale of APIs and intermediates, this company has expanded massively even in overseas markets. They have been said to have their manufacturing units lined up to produce CRAMS as well, an add on to their list of products.
This products contains a whole lot of potential for growth and expansion. To fulfil the production needs, the company has set up 8 manufacturing units or facilities across the nation. The reactor capacity of each of the facility is 1200 KL and each one of them is multipurpose.
Registered office of Arch Pharmalabs is situated in Andheri East, Mumbai. The company’s business segments, including services are API Manufacturing, Intermediate Manufacturing and contact services.
Arch Pharmalabs IPO – Financial Statements
A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:
Financial Summary:
Amount (in INR & Million) | ||||
30-Jun-20 | 31-Mar-20 | Mar-19 | 31-Mar-18 | |
Total Assets | ||||
*Total Revenue | ||||
Total Expense | ||||
Profit After Tax |
Earnings per Equity Share (in Million)
30-Jun-20 | 31-Mar-20 | Mar-19 | 31-Mar-18 |
|
Basic & Diluted |
Further, their PAT for the period ended on June 30, 2020, March 31, 2020, March 31, 2019, and March 31, 2018, were Rs. 135.51 Million, Rs. 447.45 Million, Rs. 68.04 Million and Rs. 26.91 Million respectively.
Arch Pharmalabs IPO – Promoters
The Promoter of this company is:
List of Related Parties (Key Managerial Personnel)
- Mr. Manish Kumar Dabkara, Chairman & Managing Director
- Mr. Naveen Sharma, Chief Financial Officer
- Mr. Babita Kumawat, Company Secretary and Compliance Officer
Arch Pharmalabs IPO – Promoters Holding
- Pre Issue Share Holding – %
- Pos Issue Share Holding – %
Arch Pharmalabs IPO Offer Details or Issue Details
Particulars | No. Of Equity Shares |
Equity Shares Offered | Up to X Equity Shares aggregating up to Rs.[●] Million |
of which: | |
Issue Reserved for the Market Makers | Up to [●] Equity Shares aggregating up to Rs.[●] Million |
Net Issue to the Public | Up to [●] Equity Shares aggregating up to Rs.[●] Million |
Of which: | |
Retail Investors Portion | Not less than [●] Equity Shares |
Other than Retail Individual Investors | Not more than [●] Equity Shares |
Equity Shares outstanding prior to the Issue | X Equity Shares |
Equity Shares outstanding after the Issue | X Equity Shares |
Arch Pharmalabs IPO Issue Object
Their Company proposes to utilise the Net Proceeds towards funding the following objects:
1. To meet Working Capital requirements
2. General Corporate Purpose
3. To meet issue expenses
Arch Pharmalabs IPO – Business Strategy
- Focus on Consultancy Business and spreading awareness about carbon neutrality
- Increase the use of technology to improve operational efficiency
- Expanding their customer base
- Creating awareness to reduce carbon emissions
Arch Pharmalabs IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- Quality Assurance, timely payment, and delivery
- Broad customer base and strong relationships with their customers
- Multiple Business verticals under one roof
- Qualified management team and employee base
The relevant quantitative factors are:
Basic & Diluted EPS | RONW (%) | NAV (Rs.) | |
31-Mar-20 | |||
31-Mar-19 | |||
Mar-18 |
Arch Pharmalabs IPO: Competitive Peers
Face Value (Rs.) | P/E | EPS (Rs.) | Return on Net Worth (%) | Total Income (Rs. in Crores) | |
Arch Pharmalabs Limited | 10 | [●] | 8.86 | 73.11 | 20.43 |
Listed Peers | |||||
Mitcon Consultancy and Engineering Services Limited |
10 | 12.46 | 3.13 | 3.91% | 42.72 |
Arch Pharmalabs IPO Lead Managers
Lead Managers |
Arch Pharmalabs IPO Registrar to offer
Registrar to the Offer |
BIGSHARE SERVICES PRIVATE LIMITED Address:-1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road, Marol, Andheri East, Mumbai – 400059 Tel No.:+91-022-62638200 Fax No.: +91-022-62638299 Website:www.bigshareonline.com Email:ipo@bigshareonline.com Investor Grievance Email: investor@bigshareonline.com |
Arch Pharmalabs IPO – Other Details
- Statutory Auditor – NA
- Legal Counsel to the Company – NA
- Bankers to the Company – NA
Arch Pharmalabs IPO Review by Stock Brokers
Top Stock Brokers Review | Company Reputation | Competitive Edge | Financial Statement | Popularity Index | Promoters Reputation |
Angel Broking | 7.5/10 | 7.4/10 | 8.5/10 | 8.1/10 | 7.1/10 |
Sharekhan | 7.2/10 | 7.1/10 | 8.6/10 | 8.1/10 | 7.2/10 |
Kotak Securities | 7.3/10 | 7.5/10 | 8.4/10 | 8.1/10 | 7.3/10 |
ICICI Direct | 7.3/10 | 7.3/10 | 8.7/10 | 8.1/10 | 7.1/10 |
IIFL | 7.5/10 | 7.2/10 | 8.8/10 | 8.0/10 | 7.1/10 |
Edelweiss | 7.5/10 | 7.4/10 | 8.4/10 | 8.3/10 | 7.2/10 |
Zerodha | 7.4/10 | 7.1/10 | 8.5/10 | 8.1/10 | 7.0/10 |
5Paisa | 7.1/10 | 7.1/10 | 8.4/10 | 8.1/10 | 7.1/10 |
Karvy | 7.4/10 | 7.3/10 | 8.2/10 | 8.1/10 | 7.1/10 |
Motilal Oswal | 7.1/10 | 7.1/10 | 8.6/10 | 8.3/10 | 7.2/10 |
Subscribe to Arch Pharmalabs IPO
Arch Pharmalabs Limited IPO News
News 1 – Arch Pharmalabs Limited IPO DRHP Download
News 2 – Arch Pharmalabs IPO RHP Download
Arch Pharmalabs IPO Review FAQs
Ques – What is the Issue Size of Arch Pharmalabs IPO?
Answer – The Company is making an initial public offer of NA equity shares. We vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and the net issue.
Ques – What is the Price band of Arch Pharmalabs IPO?
Answer – The price band for this particular IPO, i.e. Arch Pharmalabs IPO ranges between NA. As far as the face value of the share is of concern, it is Rs.10 per share.
Ques – What is the Arch Pharmalabs IPO Open Date?
Answer – The opening and closing dates for Arch Pharmalabs IPO have been updated. The IPO is set to open on NA, while the closing date is set at NA.
Ques – What is the Arch Pharmalabs IPO Allotment Date?
Answer – We also have the news regarding the respective allotment dates of Arch Pharmalabs IPO. Basis of Allotment finalization is on NA, refund initiation is on NA, credit of shares is on NA, and share listing date is on NA.
Ques – What is the Arch Pharmalabs IPO Listing Date?
Answer – Shares of Arch Pharmalabs shall be listed in the exchanges NA. The date, when the listing would be done, is stagnant on NA.
Ques – Who is the Registrar of Arch Pharmalabs IPO?
Answer – One of the reputed registrars is managing the issue of Arch Pharmalabs IPO, i.e. Bigshare Services Private Limited. Their website will help you regarding the further information you are on the lookout for.
Ques – Who is the Promoter of Arch Pharmalabs IPO?
Answer – Here are the promoters of Arch Pharmalabs – NA. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
Ques – What is GMP of Arch Pharmalabs IPO?
Answer – We have obtained the GMP of Arch Pharmalabs IPO and it is NA. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.
Ques – Is Arch Pharmalabs IPO good for Investment?
Answer – We have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
Ques – What is the PAT of Arch Pharmalabs Company?
Answer – We have the information of company financials, and according to that, we have the figures from the last few years to provide. PAT for the financial year 2020 in Million is NA, 2019 is NA, 2018 is NA. PAT from Sep 2020 is NA.
Calculate your return on investment!
Asset Class
ROI (Rs.)
Profit (Rs.)
Profit (%)
IPO
Equity
Savings
Real Estate
Gold
Bonds
Fixed Deposit
Mutual Fund
Market Guide
Featured Topics